Results 71 to 80 of about 32,295 (302)
Treatment-resistant schizophrenia criteria.
, 2023 Treatment-resistant schizophrenia refers to cases in which the symptoms of schizophrenia persist despite adequate and sufficient treatment with antipsychotics.
Mishell Sarmiento (16992311) +7 more
core +2 more sources
Journal of Intelligent Medicine, EarlyView.Abstract In recent years, the clinical treatment and symptom management of neurological disorders have faced significant challenges due to the high complexity of the nervous system's structure and function. Against this backdrop, physical stimulation techniques have emerged as a vital complementary approach to traditional pharmacological treatments and
Wanying Li, Liqun Chen
wiley +1 more source
Protocol: Treatment-resistant schizophrenia criteria.
, 2023 Treatment-resistant schizophrenia, also known as refractory schizophrenia, is a severe and debilitating form of chronic psychotic disorder. It is characterized by persistent and disabling symptoms such as hallucinations, delusions, thought disorders, and
Josselyn Anjhela Bravo (16711632)
core +1 more source
Journal of Employment Counseling, EarlyView.ABSTRACT This study explores how social capital and chronic illness self‐management influence career development competency among young people with chronic disabling health conditions (YPCDHC) in Hong Kong. Using data from 485 participants aged 15–29, path analysis showed that school/workplace social capital had the strongest positive effects on career
Steven Sek‐yum Ngai +10 more
wiley +1 more source
Clinical Case Reports, 2021 Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.
Tommaso Accinni +10 more
doaj +1 more source
The treatment of resistant schizophrenia [PDF]
, 2020 Department of Psychiatry, Narcology and Medical Psychology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26 ...
Putină, Cristina
core
Medicine Bulletin, EarlyView.ABSTRACT The 2024 International Conference on Functional Neurological Disorders brought together clinicians, researchers, advocates, and service‐user representatives to discuss recent developments in functional neurological disorder and related functional disorders.
Yadira Velazquez‐Rodriquez +2 more
wiley +1 more source
Phytotherapy Research, EarlyView.ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve +6 more
wiley +1 more source
Cotard and Capgras Syndrome in a Patient with Treatment-Resistant Schizophrenia
Case Reports in Psychiatry, 2021 The presentation of both Cotard and Capgras syndromes is uncommon in schizophrenia. We present a case of a 23-year-old male with the diagnosis of schizophrenia with Cotard syndrome who later developed Capgras syndrome.
Joshep Revilla +2 more
doaj +1 more source
Descriptive statistics of treatment resistant schizophrenia predictors.
, 2022 Descriptive statistics of treatment resistant schizophrenia predictors.
Megan Pritchard (228870) +17 more
core +1 more source